Elizabeth Bekiroglu
General Counsel bij ICOSAVAX, INC.
Profiel
Elizabeth Barclay Bekiroglu is currently the Secretary & General Counsel at Icosavax, Inc. Prior to this, she worked as an Associate General Counsel at Seagen Inc. from 2016 to 2021.
She also worked as an Associate at Fenwick & West LLP and Orrick, Herrington & Sutcliffe LLP.
Ms. Bekiroglu received her undergraduate degree from Stanford University and her graduate degree from Harvard Law School.
Actieve functies van Elizabeth Bekiroglu
| Bedrijven | Functie | Begin |
|---|---|---|
| ICOSAVAX, INC. | General Counsel | 10-09-2021 |
Eerdere bekende functies van Elizabeth Bekiroglu
| Bedrijven | Functie | Einde |
|---|---|---|
| SEAGEN INC. | General Counsel | 01-09-2021 |
Orrick, Herrington & Sutcliffe LLP
 Orrick, Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Orrick, Herrington & Sutcliffe LLP engages in the provision of legal services. Its practices include: antitrust and competition; banking and finance; capital markets; copyright, trademark and false advertising; cyber, privacy and data innovation; employment law and litigation; energy; financial services litigation; global compliance and regulatory, infrastructure; intellectual property; patents; public finance; real estate; securities litigation; supreme court and appellate; tax advocacy; technology transactions; trials; and white collar, investigations, securities litigation and compliance. The company was founded by John R. Garboe in 1863 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Opleiding van Elizabeth Bekiroglu
| Stanford University | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Orrick, Herrington & Sutcliffe LLP
Orrick, Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Orrick, Herrington & Sutcliffe LLP engages in the provision of legal services. Its practices include: antitrust and competition; banking and finance; capital markets; copyright, trademark and false advertising; cyber, privacy and data innovation; employment law and litigation; energy; financial services litigation; global compliance and regulatory, infrastructure; intellectual property; patents; public finance; real estate; securities litigation; supreme court and appellate; tax advocacy; technology transactions; trials; and white collar, investigations, securities litigation and compliance. The company was founded by John R. Garboe in 1863 and is headquartered in San Francisco, CA. | Commercial Services |
Icosavax, Inc.
 Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
